Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 3, Pages 422
Publisher
MDPI AG
Online
2019-03-27
DOI
10.3390/cancers11030422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC)
- (2018) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art
- (2018) Cedric Lebacle et al. WORLD JOURNAL OF UROLOGY
- Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) and sarcomatoid dedifferentiation (sRCC) after treatment with immune checkpoint inhibitors (ICI): A single-institution retrospective study.
- (2018) Jeremy Aaron Ross et al. JOURNAL OF CLINICAL ONCOLOGY
- Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
- (2016) Y. Lou et al. CLINICAL CANCER RESEARCH
- Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations
- (2016) Gabriel G. Malouf et al. EUROPEAN UROLOGY
- Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma
- (2016) Mark Bi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma
- (2015) M. Dror Michaelson et al. CANCER
- PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma
- (2015) Yiwei Wang et al. MEDICAL ONCOLOGY
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
- (2015) Abdullah Alsuliman et al. Molecular Cancer
- Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent
- (2015) Megan M. Merrill et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
- (2015) R. W. Joseph et al. Cancer Immunology Research
- The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
- (2013) Brett Delahunt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis
- (2011) Shuji Mikami et al. LABORATORY INVESTIGATION
- Combination of Gemcitabine and Doxorubicin in Rapidly Progressive Metastatic Renal Cell Carcinoma and/or Sarcomatoid Renal Cell Carcinoma
- (2011) G. Roubaud et al. ONCOLOGY
- Chromophobe Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 145 Cases
- (2008) Mahul B. Amin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy
- (2008) Ali Reza Golshayan et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started